Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mitochondrial ribosomal protein L50 pseudogene 4 (MRPL50P4) is a processed pseudogene located on human chromosome 10q23.1[6]. It is derived from the nuclear-encoded mitochondrial ribosomal protein L50 (MRPL50), which contributes to mitochondrial protein synthesis within the large (39S) mitoribosomal subunit[5]. Unlike the functional gene MRPL50, MRPL50P4 does not encode a functional protein and is not implicated directly in protein translation, disease mechanisms, or as a drug target. Although some pseudogenes have regulatory or disease associations, there is currently no evidence that MRPL50P4 plays a biological, diagnostic, or therapeutic role[1][6].\nIf you are interested in functional mitochondrial ribosomal proteins as therapeutic or biomarker targets, you should refer to the protein-coding parent gene, MRPL50[5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrial ribosomal protein L50 pseudogene 4 (MRPL50P4).